Skip to content
Chandan Healthcare logo

Chandan Healthcare

CHANDAN NSE
₹229.35 −3.10 (−1.33%)
P/E
22.66
View as Markdown
MCP
Close 4 Nov 2026 ₹229.35 −96.75 −29.7% 1Y
Start ₹326.10

Key Fundamentals

SMEHealthcare ServicesHealthcare

Price-based figures as of · EPS basis: Consolidated · TTM

ROCE
23.30%
Debt to Equity
0.32
EPS (TTM)
₹10.12
Book Value
₹69.48
Market Cap
—
P/E (TTM)
22.66
P/B
3.30
ROE
19.80%
Dividend Yield
0.00%
EBITDA
₹56.80 Cr
52W High
₹358.00
52W Low
₹185.40
Day Range
₹228.00 – ₹230.25
Volume
7,200

Peer Comparison

Healthcare › Healthcare Services › Healthcare Service Provider

Chandan Healthcare peer comparison
Dr Lal Pathlabs
₹2,029.4062.75₹32,036 Cr13.580.26%22.30%28.00%₹2,891 Cr₹545 Cr
Vijaya Diagnostic Centre
₹1,424.6078.15₹14,588 Cr15.330.14%18.30%20.50%₹857 Cr₹187 Cr
Metropolis Healthcare
₹581.2559.74₹11,437 Cr8.030.88%13.60%17.80%₹1,710 Cr₹203 Cr
Thyrocare Technologies
₹495.5044.72₹7,723 Cr14.252.90%28.40%35.40%₹876 Cr₹176 Cr
Nephrocare Health Services
₹622.35148.53₹5,903 Cr5.610.00%8.83%15.30%₹1,053 Cr₹85 Cr
Suraksha Diagnostic
₹333.0548.41₹1,717 Cr7.080.15%14.20%17.30%₹325 Cr₹35 Cr
Krsnaa Diagnostics
₹483.0515.84₹1,571 Cr1.510.41%10.90%12.70%₹726 Cr₹98 Cr
Chandan Healthcare (this company)
₹229.3522.66₹568 Cr3.300.00%19.80%23.30%₹289 Cr₹25 Cr
Median 8 companies₹538.3854.08₹6,813 Cr7.560.21%16.25%19.15%₹867 Cr₹137 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

46 Average

Data confidence 98/100

Category scores

Quality
50
Average
Returns, margins, earnings quality 22% weight
Valuation
52
Average
Cheap vs sector & own history 24% weight
Growth
70
Strong
Sales & profit trajectory 9% weight
Financial Health
42
Weak
Solvency, leverage, coverage 9% weight
Momentum
27
Poor
Trend strength, vol-adjusted 12% weight
Ownership
32
Poor
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company has a good return on equity (ROE) track record: 3 Years ROE 25.7%

Weaknesses

4
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -2.41%
  • Debtor days have increased from 82.7 to 114 days.
  • Working capital days have increased from 48.3 days to 95.2 days

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBearish973
OscillatorsBearish270
Moving AveragesStrong Bearish703

Key readings

RSI (14)
49.78
Neutral
MACD (12,26,9)
0.85
Bearish
SMA (50)
224.06
Bullish
SMA (200)
243.81
Bearish

As of

Growth Rate

From the financial statements below. 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
3Y+26.30%
1Y+20.00%

Net profit

Net profit growth by window
3Y+113.02%
1Y+20.83%

Operating cash flow

Operating cash flow growth by window
3Y+58.74%
1YTurned positive

Operating margin· change in pp

Operating margin growth by window
3Y+12.63 pp
1Y+1.81 pp

Trailing twelve months: Fewer than eight quarters are reported, so there is no trailing-twelve-month figure.

Revenue by year

Revenue by year, ₹ crore
Mar 2022₹120 Cr
Mar 2023₹137 Cr
Mar 2024₹177 Cr
Mar 2025₹230 Cr
Mar 2026₹276 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2022−₹1.00 Cr
Mar 2023₹3.00 Cr
Mar 2024₹16.00 Cr
Mar 2025₹24.00 Cr
Mar 2026₹29.00 Cr

Quarterly Results

₹ Cr
CHANDAN quarterly results, ₹ crore
Particulars Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
54.64
62.65
67.9
67.9
65.01
75.58
80.85
Expenses
45.75
52.41
54.03
53.75
53.17
64.1
61.27
Operating Profit
8.89
10.24
13.87
14.15
11.84
11.48
19.58
OPM %
16.27%
16.34%
20.43%
20.84%
18.21%
15.19%
24.22%
Other Income
0.17
2.42
0.87
0.84
−1.46
1.85
1.41
Interest
1.09
1.3
1.37
1.4
1.28
1.78
4.83
Depreciation
1.35
2.7
3.75
2.46
2.4
3.74
4.47
PBT
6.62
8.66
9.62
11.13
6.7
7.81
11.69
Tax %
30.21%
29.56%
35.65%
25.79%
24.93%
36.62%
32.34%
Net Profit
4.2
6.02
6.19
7.8
4.54
4.94
7.92
EPS (₹)
2.1
2.46
2.37
3.19
1.86
2
3.07

Profit & Loss

₹ Cr
CHANDAN profit and loss, annual, ₹ crore
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
120
137
177
230
276
289
Expenses
117
128
150
190
224
232
Operating Profit
2
9
26
40
53
57
OPM %
1.9%
7%
15%
18%
19%
20%
Other Income
0
0
1
3
1
3
Interest
2
2
3
5
6
9
Depreciation
2
2
3
7
10
13
PBT
−1
5
21
32
38
37
Tax %
3%
28%
24%
27%
25%
—
Net Profit
−1
3
16
24
29
25
EPS (₹)
−0.56
1.68
8.14
9.07
11.07
10.12
Div. Payout %
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
CHANDAN balance sheet, annual, ₹ crore
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
20
20
20
24
24
Reserves
4
7
21
98
147
Borrowings
17
21
36
48
54
Other Liabilities
41
49
41
40
65
Total Liabilities
82
98
118
211
290
Fixed Assets
29
33
48
76
101
CWIP
0
0
0
4
12
Investments
6
7
3
33
20
Other Assets
46
58
66
98
156
Total Assets
82
98
118
211
290

Cash Flow

₹ Cr
CHANDAN cash flow, annual, ₹ crore
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
6
4
1
−3
16
Investing
−11
−6
−15
−62
−40
Financing
3
2
16
67
21
Net Cash Flow
−1
0
2
2
−3
Free Cash Flow
−1
−1
−18
−41
−26
CFO/EBITDA
275
60
23
14
49

Ratios

CHANDAN financial ratios, annual
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
88
63
59
75
114
Inventory Days
46
71
96
126
112
Days Payable
185
251
102
103
135
Cash Conversion Cycle
−51
−117
53
98
92
Working Capital Days
−11
−21
−1
50
95
ROCE %
—
16%
37%
29%
23%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Chandan Healthcare insights

58 extracted metrics across FY22–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 48.42%
  • Public 38.77%
  • Others 7.75%
  • DIIs 5.06%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Chandan Healthcare

What does Chandan Healthcare Ltd do?
Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centers in North India with pathology and radiology testing services.
Where is Chandan Healthcare Ltd (CHANDAN) listed?
Chandan Healthcare Ltd trades as CHANDAN on the NSE.
Which sector does Chandan Healthcare Ltd belong to?
Chandan Healthcare Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the PE ratio of Chandan Healthcare Ltd?
Chandan Healthcare Ltd trades at a PE ratio of 22.66 as of 4 Nov 2026, on earnings per share of ₹10.12, against a book value of ₹69.48 per share.
What is the 52-week high and low of Chandan Healthcare Ltd?
Over the last 52 weeks Chandan Healthcare Ltd has traded between ₹185.4 and ₹358 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Chandan Healthcare Ltd?
Chandan Healthcare Ltd reported a return on equity of 19.80%. Its debt-to-equity ratio is 0.32.

Company Information

Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centers in North India with pathology and radiology testing services.

Website chandandiagnostic.com
Listed 17 Feb 2025
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/CHANDAN.md for Chandan Healthcare Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month